Merus Eulerpool naujienos

Merus Eulerpool News

Merus akcijų naujienos

Merus stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Merus naujienas mes pateikiame čia.

• spalio 17 d. ·

  Yahoo
  Investing in Merus (NASDAQ:MRUS) five years ago would have delivered you a 227% gain
• spalio 16 d. ·

  Yahoo
  MeiraGTx (MGTX) Surges 14.9%: Is This an Indication of Further Gains?
• spalio 15 d. ·

  GuruFocus
  BOXER CAPITAL, LLC Expands Stake in ITeos Therapeutics Inc
• spalio 15 d. ·

  GuruFocus
  SILVERARC CAPITAL MANAGEMENT, LLC Acquires Shares in Elutia Inc
• spalio 10 d. ·

  TipRanks
  Buy Rating Affirmed for Merus with Promising Outlook on Petosemtamab’s Clinical and Market Potential
• spalio 8 d. ·

  Thefly.com
  Bicara Therapeutics initiated with bullish view at Morgan Stanley, here's why
• spalio 8 d. ·

  Thefly.com
  Bicara Therapeutics initiated with an Overweight at Morgan StanleyMerus
• spalio 1 d. ·

  Thefly.com
  Merus price target raised by $18 at Guggenheim, here's why
• rugsėjo 30 d. ·

  Yahoo
  Merus Announces First Patient Dosed in LiGeR-HN1, a Phase 3 Trial Evaluating Petosemtamab in Combination with Pembrolizumab in 1L r/m HNSCC
• rugsėjo 30 d. ·

  TipRanks
  Buy Rating Affirmed for Merus on Strong Clinical Trial Progress and Competitive Positioning